Cargando…
Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications
The SARS‐CoV‐2 virus causes COVID‐19, an infection capable of causing severe disease and death but which can also be asymptomatic or oligosymptomatic. We investigated whether ABO blood group or secretor status was associated with COVID‐19 severity. We investigated secretor status because expression...
Autores principales: | Mankelow, Tosti J., Singleton, Belinda K., Moura, Pedro L., Stevens‐Hernandez, Christian J., Cogan, Nicola M., Gyorffy, Gyongyver, Kupzig, Sabine, Nichols, Luned, Asby, Claire, Pooley, Jennifer, Ruffino, Gabriella, Hosseini, Faroakh, Moghaddas, Fiona, Attwood, Marie, Noel, Alan, Cooper, Alex, Arnold, David T., Hamilton, Fergus, Hyams, Catherine, Finn, Adam, Toye, Ashley M., Anstee, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176350/ https://www.ncbi.nlm.nih.gov/pubmed/34124710 http://dx.doi.org/10.1002/jha2.180 |
Ejemplares similares
-
A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration
por: Bryer, Emily J., et al.
Publicado: (2020) -
Age‐specific differences in the magnitude of malaria‐related anemia during low and high malaria seasons in rural Zambian children
por: Acheampong, Clement O., et al.
Publicado: (2021) -
Plasma exchange for COVID‐19 thrombo‐inflammatory disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020) -
Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021) -
Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020)